Intellectual Property India Publishes Patent Application for “a Pharmaceutical Composition For Treatment Of Epidermal Growth Factor Receptor (egfr)-Mutant Non-Small Cell Lung Cancer”

MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202641074776 A) filed by Vellore Institute Of Technology on June 17, 2026, for “a Pharmaceutical Composition For Treatment Of Epidermal Growth Factor Receptor (egfr)-Mutant Non-Small Cell Lung Cancer”.

Inventors include Dr. Sudandiradoss C; Poobana Dharmalingam; and Alisha Martha Joseph.

The application for the patent was published on June 26, 2026, under issue no. 26/2026.

Abstract: The present invention relates to pharmaceutical compositions and methods for treating epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), particularly NSCLC associated with treatment-resistant EGFR mutations. The invention provides a pharm...